Home/Filings/4/0001104659-15-012643
4//SEC Filing

NPS PHARMACEUTICALS INC 4

Accession 0001104659-15-012643

CIK 0000890465operating

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 4:46 PM ET

Size

20.5 KB

Accession

0001104659-15-012643

Insider Transaction Report

Form 4
Period: 2015-02-07
Rogus Joseph J
VP, Technical Operations
Transactions
  • Tax Payment

    Common Stock

    2015-02-07$45.85/sh1,132$51,90219,019 total
  • Exercise/Conversion

    Common Stock

    2015-02-12+1,56720,586 total
  • Tax Payment

    Common Stock

    2015-02-12$45.85/sh705$32,32419,881 total
  • Other

    Common Stock

    2015-02-07+3,76720,151 total
  • Exercise/Conversion

    Common Stock

    2015-02-13+3,24023,121 total
  • Tax Payment

    Common Stock

    2015-02-13$45.88/sh1,458$66,89321,663 total
  • Exercise/Conversion

    Restricted Stock Units

    2015-02-121,5673,136 total
    Common Stock (1,567 underlying)
  • Award

    Restricted Stock Units

    2015-02-12+4,3624,362 total
    Common Stock (4,362 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2015-02-133,2403,241 total
    Common Stock (3,240 underlying)
Footnotes (8)
  • [F1]Shares acquired upon vesting of Restricted Stock Units granted to the Reporting Person on February 7, 2012 and reported on a Form 4 filed on February 9, 2012.
  • [F2]The Reporting Person reported all Restricted Stock Units granted to the Reporting Person on February 7, 2012 in Table I of the Form 4 filed on February 9, 2012. As such, no adjustment to the Reporting Person's beneficial ownership needs to be made to reflect this vesting event.
  • [F3]Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the Restricted Stock Units described in this Form 4.
  • [F4]Each vested Restricted Stock Unit is the economic equivalent of one share of common stock of NPS Pharmaceuticals, Inc. (the "Issuer"). The vested Restricted Stock Units were settled for shares of the Issuer's common stock.
  • [F5]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F6]On February 12, 2014, the Restricted Stock Units were granted with (i) one third vesting on the first anniversary of the date of grant, (ii) one third vesting on the second anniversary of the date of grant and (iii) the remaining vesting on the third anniversary of the date of grant.
  • [F7]Restricted Stock Units will vest as follows: (i) one third will vest on the first anniversary of date of grant, (ii) one third on the second anniversary of date of grant, and (iii) one third on the third anniversary of date of grant. Vested shares will be delivered to the Reporting Person as soon as administratively practicable following the vesting of the Restricted Stock Units.
  • [F8]On February 13, 2013, the Restricted Stock Units were granted with (i) one third vesting on the first anniversary of the date of grant, (ii) one third vesting on the second anniversary of the date of grant and (iii) the remaining vesting on the third anniversary of the date of grant.

Documents

1 file

Issuer

NPS PHARMACEUTICALS INC

CIK 0000890465

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000890465

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:46 PM ET
Size
20.5 KB